Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

An Alabama grandmother who was the first patient to receive a new kind of genetically modified pig kidney more than two ...

In line with President Ferdinand Marcos Jr.'s assurance of continuous expansion in healthcare benefits despite zero subsidy, the Philippine Health Insurance Corporation (PhilHealth) has substantially ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with ...

The FDA approval is based on results from a trial investigating the effects of once-a-week Ozempic injections on major kidney ...

In a groundbreaking medical milestone, doctors in Kumasi have successfully conducted the first-ever kidney transplant in the Ashanti Region. This historic procedure took place at HopeXchange Medical ...